← Leaderboards
Tuan Manh Tran
Indiana University Indianapolis
$6,960,203
Attributed
$9,229,739
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.7M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,229,739 · 7
By mechanism
R01$7,302,202 · 3
K08$926,120 · 1
R21$842,917 · 2
R03$158,500 · 1
Top collaborators
- Megan Song Mchenry2 shared
- Samir Kumar Gupta1 shared
- Jesse C Stewart1 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Takashi Hato$2,762,037
- Jesse C Stewart$7,758,171
- Dustin Hammers$493,379
- Megan Song McHenry$5,166,396
- Thomas D. Hurley$11,294,425
Others in their field
Other Emerging Leaders on “Cessation Of Life”
- Xinhua Li · Nano Terra, Inc.$32,520,955
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Abraham Aizer Brody · New York University School Of Medicine$21,799,826
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$20,810,724
- Jeffrey Reich · Sparian Biosciences, Inc.$20,633,040
- Beth Baseler · Leidos Biomedical Research, Inc.$18,109,529
Research focus
Cessation Of LifeBloodMalariaInfectionChildParasitemiaPlasmodium FalciparumParasitesResponseLiverInsightIn VitroMalaria TransmissionAreaImmuneSamplingCytokineMortalityMolecularImmunityPlasmaPreventAfricanBlood Specimen
Grant awards (18)
HIV, Depression, and Insulin Resistance$3,096,280
R01 · FY2025 · DK
A systems analysis to understand the differential pharmacokinetics and protective efficacy of anti-malarial monoclonal antibodies in field trials.$781,241
R01 · FY2025 · AI · contact PI
Evaluating the role of P53 pathways in malaria$685,219
R01 · FY2025 · AI · contact PI
Assessing the Impact of Treatment of Asymptomatic Malaria Infections on Inflammation and Cognition in Schoolchildren$115,309
R21 · FY2025 · AI · contact PI
Evaluating the role of P53 pathways in malaria$726,260
R01 · FY2024 · AI · contact PI
Assessing the Impact of Treatment of Asymptomatic Malaria Infections on Inflammation and Cognition in Schoolchildren$295,390
R21 · FY2024 · AI · contact PI
Evaluating the role of P53 pathways in malaria$690,502
R01 · FY2023 · AI · contact PI
Evaluating the role of P53 pathways in malaria$684,261
R01 · FY2022 · AI · contact PI
Investigating gene regulatory networks in immune cells of children who differ in susceptibility to malaria infection using single-cell approaches$115,218
R21 · FY2022 · AI · contact PI
Validation and characterization of antibody responses to Plasmodium falciparum antigens identified by protein array screening$79,250
R03 · FY2022 · AI · contact PI
Evaluating the role of P53 pathways in malaria$638,439
R01 · FY2021 · AI · contact PI
Investigating gene regulatory networks in immune cells of children who differ in susceptibility to malaria infection using single-cell approaches$317,000
R21 · FY2021 · AI · contact PI
Defining clinical and sterile immunity to Plasmodium falciparum infection using systems biology approaches$185,224
K08 · FY2021 · AI · contact PI
Validation and characterization of antibody responses to Plasmodium falciparum antigens identified by protein array screening$79,250
R03 · FY2021 · AI · contact PI
Defining clinical and sterile immunity to Plasmodium falciparum infection using systems biology approaches$185,224
K08 · FY2020 · AI · contact PI
Defining clinical and sterile immunity to Plasmodium falciparum infection using systems biology approaches$185,224
K08 · FY2019 · AI · contact PI
Defining clinical and sterile immunity to Plasmodium falciparum infection using systems biology approaches$185,224
K08 · FY2018 · AI · contact PI
Defining clinical and sterile immunity to Plasmodium falciparum infection using systems biology approaches$185,224
K08 · FY2017 · AI · contact PI